Last edition
News about "Dr Massimo Cristofanilli"
Sathgen Therapeutics Expands Global Footprint with US Subsidiary Launch
Sathgen Therapeutics has expanded its global presence with the launch of a US-based subsidiary, appointing Dr Padmaja Ganpathy as Chief Executive Officer and Dr Sendurai Mani as Chief Scientific Officer to lead its next phase of growth and innovation.
Dr Massimo Cristofanilli | 18/12/2025 | By News Bureau | 167
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members